Heart Failure Software Market - Global Forecast 2026-2032

The heart failure software market is advancing rapidly, driven by the convergence of digital health innovations, enhanced clinical workflows, and evolving regulatory frameworks. Senior healthcare leaders recognize the need to optimize heart failure management solutions for operational efficiency, compliance, and improved patient outcomes.

Market Snapshot: Heart Failure Software Market Growth

The heart failure software market is on a solid upward growth path, expanding from a base of USD 2.65 billion in 2025 to USD 2.83 billion in 2026, reflecting a projected compound annual growth rate (CAGR) of 7.42%. This significant traction aligns with structural shifts in healthcare, including the growing complexity of clinical requirements, widespread adoption of digital care models, and the evolution of international regulatory policies. Market attention is notably concentrated among enterprise IT leaders, clinical executives, and strategic procurement professionals focused on implementing solutions that align technology investment with operational and clinical goals. These factors are reshaping procurement strategies and the approach organizations take to technology adoption across healthcare systems worldwide.

Scope & Segmentation: Defining the Market Landscape

Solution Types: Encompasses knowledge-based platforms supporting clinical rules alongside data-driven systems that learn continuously from aggregated patient datasets.
Disease Focus: Addresses modules designed for congenital heart failure with pediatric features, left-sided failure with in-depth hemodynamic analytics, and right-sided heart failure focusing on diverse clinical data integration.
Platform Architectures: Incorporates integrated systems combining analytics, monitoring, and workflow management, as well as focused standalone offerings targeting specific operational or clinical needs.
Application Scope: Spans clinical decision support, predictive analytics, remote patient monitoring, seamless EMR integration, telehealth, and patient engagement—demonstrating the multi-faceted demands of modern care environments.
End-User Context: Serves hospitals, clinics, and homecare settings, each with unique workflow, security, and user engagement priorities that influence software deployment strategies.
Deployment Choices: Supports cloud-based, on-premises, and web-based software implementations, allowing organizations to define preferred levels of data control, security, and integration in line with local requirements.
Regional Markets: Includes Americas, EMEA, and Asia-Pacific, recognizing the distinct health reimbursement models, regulatory landscapes, and digital infrastructure maturity influencing technology adoption across regions.

Key Takeaways: Strategic Insights for Stakeholders

New interoperability standards and streamlined regulatory requirements are simplifying system integration, increasing software adoption in diverse healthcare settings.
The expansion of artificial intelligence and machine learning functionalities equips clinicians with deeper insights for heart failure risk assessment and personalized treatment pathways.
Growing reliance on hybrid care models highlights the need for platforms supporting remote patient monitoring and active engagement to facilitate continuous care transitions.
Providers and vendors that prioritize validated clinical performance, strong interoperability, and seamless device and EMR integration achieve measurable operational advantages.
Flexible deployment models and modular contracting enable organizations to customize solutions according to local compliance and workflow needs.
Investment in explainable AI, post-market evaluation, and robust cybersecurity measures are vital to addressing requirements set by payers, regulators, and patient advocacy groups.

Tariff Impact: Policy Shifts Reshaping Supply and Deployment

Shifting tariff frameworks since 2025 have influenced heart failure software supply chains and deployment planning, especially for systems reliant on linked hardware and support services. Enterprises are prioritizing partners with localized manufacturing to mitigate potential supply disruptions. Cloud-first approaches and modular software architectures are increasingly favored as organizations seek to minimize hardware tariff risks, maintain business continuity, and ensure operational resilience. These strategies support flexible procurement and facilitate regionally compliant, scalable cloud deployments—enabling organizations to effectively manage regulatory changes and supply chain volatility.

Methodology & Data Sources

This market analysis draws from structured interviews with clinical leaders, IT professionals, and procurement stakeholders, combined with technical reviews of software architecture and compliance. Secondary research includes regulatory documentation, peer-reviewed literature, interoperability standards, and validated vendor information, ensuring recommendations are practical and evidence-based.

Why This Report Matters

Provides senior executives with detailed segmentation and regional perspectives essential for informed product development and procurement planning.
Clarifies the effect of tariff policy, ongoing interoperability upgrades, and the accelerating use of artificial intelligence in shaping competitive dynamics in the heart failure software market.
Enables decision-makers to identify actionable steps that align technology deployment with organizational priorities, streamlining implementation and supporting adoption across complex care networks.

Conclusion: Navigating the Future of Heart Failure Software

Organizations adopting validated, interoperable heart failure software solutions gain the ability to intervene earlier, customize care pathways, and maintain seamless operations. Focusing on strong integration, clinical credibility, and adaptable platform deployment prepares healthcare providers to succeed in a continually evolving industry landscape.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Heart Failure Software Market, by Type

8.1. Knowledge Based
8.2. Non-Knowledge Based

9. Heart Failure Software Market, by Disease Type

9.1. Congenital Heart Failure
9.2. Left-Sided Heart Failure
9.3. Right-Sided Heart Failure

10. Heart Failure Software Market, by Platform

10.1. Integrated
10.2. Standalone

11. Heart Failure Software Market, by Application

11.1. Clinical Decision Support
11.2. Data Analytics
11.3. Electronic Medical Record Integration
11.4. Mobile & Patient-centric Applications
11.5. Predictive Analytics & Risk Stratification Tools
11.6. Remote Monitoring & Telehealth Platform

12. Heart Failure Software Market, by End-User

12.1. Clinics
12.2. Homecare Settings
12.3. Hospitals

13. Heart Failure Software Market, by Deployment Model

13.1. Cloud-Based Systems
13.2. On-Premises
13.3. Web-Based

14. Heart Failure Software Market, by Region

14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific

15. Heart Failure Software Market, by Group

15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO

16. Heart Failure Software Market, by Country

16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea

17. United States Heart Failure Software Market
18. China Heart Failure Software Market

19. Competitive Landscape

19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Abbott Laboratories
19.6. AliveCor, Inc.
19.7. Astellas Pharma Inc.
19.8. Axis Clinical Software, Inc.
19.9. Biofourmis Inc.
19.10. Biome.io
19.11. BIOPAC Systems Inc.
19.12. Boston Scientific Corporation
19.13. Canon Medical Systems Corporation
19.14. Cardiac RMS, LLC by DocGo, Inc.
19.15. CitiusTech Inc.
19.16. Cleerly, Inc.
19.17. CV Medical Software
19.18. Dyad Medical Inc.
19.19. Eko Health Inc.
19.20. Elucid Bioimaging Inc.
19.21. Endotronix, Inc
19.22. Epic Systems Corporation
19.23. Foundry Innovation & Research 1 Ltd.
19.24. GE HealthCare Technologies Inc.
19.25. Heart Input Output Inc.
19.26. Implicity
19.27. International Business Machines Corporation
19.28. iRhythm Technologies, Inc.
19.29. Koninklijke Philips N.V.
19.30. Medtronic PLC
19.31. N. Harris Computer Corporation
19.32. NorthEast Monitoring, Inc.
19.33. Oracle Corporation
19.34. PaceMate, LLC
19.35. Pacertool AS
19.36. Precordior Ltd.
19.37. Siemens AG
19.38. Ultromics Limited
19.39. VectraCor Inc.
19.40. VUNO Inc.
19.41. ZOLL Medical Corporation

List of Figures

FIGURE 1. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL HEART FAILURE SOFTWARE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL HEART FAILURE SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY KNOWLEDGE BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY KNOWLEDGE BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY KNOWLEDGE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY NON-KNOWLEDGE BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY NON-KNOWLEDGE BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY NON-KNOWLEDGE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY CONGENITAL HEART FAILURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY CONGENITAL HEART FAILURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY CONGENITAL HEART FAILURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY LEFT-SIDED HEART FAILURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY LEFT-SIDED HEART FAILURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY LEFT-SIDED HEART FAILURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY INTEGRATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY INTEGRATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY INTEGRATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY STANDALONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY STANDALONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY STANDALONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY CLINICAL DECISION SUPPORT, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY CLINICAL DECISION SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY CLINICAL DECISION SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY DATA ANALYTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY DATA ANALYTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY DATA ANALYTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY ELECTRONIC MEDICAL RECORD INTEGRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY ELECTRONIC MEDICAL RECORD INTEGRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY ELECTRONIC MEDICAL RECORD INTEGRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY MOBILE & PATIENT-CENTRIC APPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY MOBILE & PATIENT-CENTRIC APPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY MOBILE & PATIENT-CENTRIC APPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY PREDICTIVE ANALYTICS & RISK STRATIFICATION TOOLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY PREDICTIVE ANALYTICS & RISK STRATIFICATION TOOLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY PREDICTIVE ANALYTICS & RISK STRATIFICATION TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY REMOTE MONITORING & TELEHEALTH PLATFORM, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY REMOTE MONITORING & TELEHEALTH PLATFORM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY REMOTE MONITORING & TELEHEALTH PLATFORM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY CLOUD-BASED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY CLOUD-BASED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY CLOUD-BASED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY ON-PREMISES, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY ON-PREMISES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY ON-PREMISES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY WEB-BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY WEB-BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY WEB-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. AMERICAS HEART FAILURE SOFTWARE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 67. AMERICAS HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 68. AMERICAS HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 69. AMERICAS HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 70. AMERICAS HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 71. AMERICAS HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 72. AMERICAS HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 73. NORTH AMERICA HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. NORTH AMERICA HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 75. NORTH AMERICA HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 76. NORTH AMERICA HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 77. NORTH AMERICA HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 78. NORTH AMERICA HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 79. NORTH AMERICA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 80. LATIN AMERICA HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. LATIN AMERICA HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 82. LATIN AMERICA HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 83. LATIN AMERICA HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 84. LATIN AMERICA HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 85. LATIN AMERICA HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 94. EUROPE HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. EUROPE HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 96. EUROPE HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 97. EUROPE HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 98. EUROPE HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 99. EUROPE HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 100. EUROPE HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 101. MIDDLE EAST HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. MIDDLE EAST HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 103. MIDDLE EAST HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 104. MIDDLE EAST HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 105. MIDDLE EAST HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 106. MIDDLE EAST HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 107. MIDDLE EAST HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 108. AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 110. AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 111. AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 112. AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 113. AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 114. AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. ASEAN HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. ASEAN HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 125. ASEAN HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 126. ASEAN HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 127. ASEAN HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 128. ASEAN HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 129. ASEAN HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 130. GCC HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GCC HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 132. GCC HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 133. GCC HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 134. GCC HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 135. GCC HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 136. GCC HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 137. EUROPEAN UNION HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. EUROPEAN UNION HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 139. EUROPEAN UNION HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 140. EUROPEAN UNION HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 141. EUROPEAN UNION HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 142. EUROPEAN UNION HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 143. EUROPEAN UNION HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 144. BRICS HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. BRICS HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 146. BRICS HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 147. BRICS HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 148. BRICS HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 149. BRICS HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 150. BRICS HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 151. G7 HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. G7 HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 153. G7 HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 154. G7 HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 155. G7 HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 156. G7 HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 157. G7 HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 158. NATO HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. NATO HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 160. NATO HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 161. NATO HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 162. NATO HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 163. NATO HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 164. NATO HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. UNITED STATES HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 167. UNITED STATES HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 168. UNITED STATES HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 169. UNITED STATES HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 170. UNITED STATES HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 171. UNITED STATES HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 172. UNITED STATES HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 173. CHINA HEART FAILURE SOFTWARE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 174. CHINA HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 175. CHINA HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 176. CHINA HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 177. CHINA HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 178. CHINA HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 179. CHINA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Heart Failure Software market report include:

Abbott Laboratories
AliveCor, Inc.
Astellas Pharma Inc.
Axis Clinical Software, Inc.
Biofourmis Inc.
Biome.io
BIOPAC Systems Inc.
Boston Scientific Corporation
Canon Medical Systems Corporation
Cardiac RMS, LLC by DocGo, Inc.
CitiusTech Inc.
Cleerly, Inc.
CV Medical Software
Dyad Medical Inc.
Eko Health Inc.
Elucid Bioimaging Inc.
Endotronix, Inc
Epic Systems Corporation
Foundry Innovation & Research 1 Ltd.
GE HealthCare Technologies Inc.
Heart Input Output Inc.
Implicity
International Business Machines Corporation
iRhythm Technologies, Inc.
Koninklijke Philips N.V.
Medtronic PLC
N. Harris Computer Corporation
NorthEast Monitoring, Inc.
Oracle Corporation
PaceMate, LLC
Pacertool AS
Precordior Ltd.
Siemens AG
Ultromics Limited
VectraCor Inc.
VUNO Inc.
ZOLL Medical Corporation

Table Information

Report Attribute	Details
No. of Pages	180
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 2.83 Billion
Forecasted Market Value ( USD ) by 2032	$ 4.37 Billion
Compound Annual Growth Rate	7.4%
Regions Covered	Global
No. of Companies Mentioned	38

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3511EUR$3,939USD£3,045GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3787EUR$4,249USD£3,285GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5133EUR$5,759USD£4,452GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6212EUR$6,969USD£5,387GBP

Market Snapshot: Heart Failure Software Market Growth

Scope & Segmentation: Defining the Market Landscape

Key Takeaways: Strategic Insights for Stakeholders

Tariff Impact: Policy Shifts Reshaping Supply and Deployment

Methodology & Data Sources

Why This Report Matters

Conclusion: Navigating the Future of Heart Failure Software

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Congestive Heart Failure Market - Global Forecast 2026-2032

Digital Heart Failure Clinic Market Report 2025

Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Global Market Report 2025

Implantable Heart Failure Monitoring Sensor Market - Global Forecast 2025-2030

Chronic Heart Failure Market - A Global and Regional Analysis: Analysis and Forecast, 2025-2035